Quantitative evaluation of electroconvulsive therapy for Parkinson's disease with refractory psychiatric symptoms (Q48311203)

10 February 2018

title

Quantitative evaluation of electroconvulsive therapy for Parkinson's disease with refractory psychiatric symptoms (English)

1 reference

10 February 2018

1 reference

5

1 reference

10 February 2018

Nobutaka Hattori

8

object named as

Nobutaka Hattori

1 reference

10 February 2018

7

Heii Arai

1 reference

10 February 2018

author name string

Kenya Nishioka

1

1 reference

10 February 2018

Ryota Tanaka

2

1 reference

10 February 2018

Hideki Shimura

3

1 reference

10 February 2018

Kazuoki Hirano

4

1 reference

10 February 2018

Koichi Miyakawa

6

1 reference

10 February 2018

Takao Urabe

9

1 reference

10 February 2018

publication date

18 April 2014

1 reference

10 February 2018

Journal of Neural Transmission

published in

1 reference

10 February 2018

volume

121

1 reference

10 February 2018

issue

11

1 reference

10 February 2018

page(s)

1405-1410

1 reference

10 February 2018

Neuropsychiatric symptoms in patients with Parkinson's disease and dementia: frequency, profile and associated care giver stress

cites work

1 reference

https://api.crossref.org/works/10.1007/S00702-014-1212-4

Depression in Parkinson disease--epidemiology, mechanisms and management.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00702-014-1212-4

An Inventory for Measuring Depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00702-014-1212-4

The Barthel ADL Index: a reliability study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00702-014-1212-4

Electroconvulsive therapy in Parkinson's disease and other movement disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00702-014-1212-4

Non-invasive brain stimulation for Parkinson's disease: a systematic review and meta-analysis of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00702-014-1212-4

Mortality and hallucinations in nursing home patients with advanced Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00702-014-1212-4

Parkinsonism: onset, progression, and mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00702-014-1212-4

Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00702-014-1212-4

Effective control of catatonia in Parkinson's disease by electroconvulsive therapy: a case report

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00702-014-1212-4

Diagnostic accuracy of mini-mental status examination and revised hasegawa dementia scale for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00702-014-1212-4

Anxiety rating scales in Parkinson's disease: critique and recommendations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00702-014-1212-4

Apathy and anhedonia rating scales in Parkinson's disease: critique and recommendations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00702-014-1212-4

Effectiveness of ECT in Patients With Parkinsonism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00702-014-1212-4

Use of electroconvulsive therapy in Parkinson disease with residual axial symptoms partially unresponsive to L-dopa: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00702-014-1212-4

Electroconvulsive therapy in Parkinson's disease: 30 month follow up

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00702-014-1212-4

A new validation of the Hamilton Rating Scale for depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00702-014-1212-4

Electroconvulsive therapy stimulus dose expressed as volume of seizure foci

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00702-014-1212-4

Systematic review of levodopa dose equivalency reporting in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00702-014-1212-4

Marked improvement of psychotic symptoms after electroconvulsive therapy in Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00702-014-1212-4

Improvements in both psychosis and motor signs in Parkinson's disease, and changes in regional cerebral blood flow after electroconvulsive therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00702-014-1212-4

Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): Scale presentation and clinimetric testing results

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S00702-014-1212-4

The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia

21 January 2018

1 reference

12 December 2020

1 reference

12 December 2020

Increased neurogenesis in a model of electroconvulsive therapy

1 reference

12 December 2020

Response rate of catatonia to electroconvulsive therapy and its clinical correlates

1 reference

12 December 2020

Electroconvulsive therapy in movement disorders: an update

1 reference

12 December 2020

Catatonic stupor during the course of Parkinson's disease resolved with electroconvulsive therapy

1 reference

12 December 2020

10.1007/S00702-014-1212-4

Identifiers

DOI

1 reference

10 February 2018

1 reference

10 February 2018